Here you can read news and press releases from Paindrainer.
Paindrainer AB is pleased to announce the formalization of a commercial partnership agreement with Dr. Edward Rubin, Past President of The New York Society of Interventional Pain Physicians. This strategic collaboration accomplishes a crucial milestone, allowing Paindrainer AB access to the U.S. market with its groundbreaking FDA registered Medical Device Class I digital solution for chronic pain management.
MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB, in collaboration with the Institute of Health Economics (IHE), has undertaken and unveiled considerable costs in a health economic study. The study underscores the substantial impact of chronic pain on the cost to both society, health organisations and payers. In addition, it also sheds light on the potential for improvement through the utilization of a digital self-management tool like Paindrainer®.
MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB is pleased to announce that the company has signed a commercial agreement with the Swedish Fibromyalgia Association, offering Paindrainer® as a complimentary membership benefit.
.png)
LUND, SWEDEN – The company is pleased to announce that the Paindrainer® App has been certified by the Organization for the Review of Care and Health Apps (ORCHA). ORCHA is the world’s leading, independent digital health evaluation and distribution organization, providing verification and certification, which is trusted and accepted by health-care organizations internationally.
MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB is proud to announce that the company’s 360° patient-centric© app Paindrainer® was announced as the winner of the Nordic Health App Award 2023 at the “Arendalsuka” in Norway.
MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB is pleased to announce that the company’s 360° patient-centric© app (Paindrainer® PD1) has received registration approval as a Medical Device Class 1 (510k exemption) by the U.S. Food and Drug Administration (FDA).
MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB announces the publication of its pivotal multi-center study in the well-respected journal Pain Medicine. The study clearly demonstrates that self-management of chronic pain using Paindrainer´s digital tool, powered by a proprietary neural network, significantly improved subjects’ pain interference, physical function, depression, anxiety, and pain catastrophizing over the 12-week study period.
MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB is pleased to announce that the company has been selected through a rigorous selection process to take part in Business Sweden’s valuable Catalysts program. In the final Paindrainer emerged as one of three companies to take part in the attractive scale-up program.
Erik Frick
CEO
[email protected]
+1 646 979 8319
Paindrainer App
JPG
Paindrainer Logotype
SVG
The Story Behind Paindrainer
Paindrainer Demo
